Stay updated on Combination Immunotherapy in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Combination Immunotherapy in Prostate Cancer Clinical Trial page.

Latest updates to the Combination Immunotherapy in Prostate Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check13 days agoChange DetectedAddition: Revision: v3.4.2 is shown, and older Revision: v3.4.1 references and Prostate cancer topic links were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a government funding notice banner with links to cc.nih.gov and opm.gov, plus related Prostate Cancer topic links and a revision note (v3.4.1); the previous revision entry (v3.4.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedAdded long-term outcome definitions (rPFS, TTR-PCWG3, DOR-PCWG3, TTP-PSA) with timeframes up to 84 months and related metric descriptions. Introduced Brazil locations (Rio de Janeiro and São Paulo) with addresses and a 'Show glossary' option on the page.SummaryDifference2%

- Check42 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3 from the page.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page adds an expanded list of study locations across multiple countries and states and removes prior location blocks, updating the geographic scope of the study sites.SummaryDifference2%

- Check92 days agoChange DetectedMinor editorial updates: the Publications section now states that PubMed publications are auto-filled and may not pertain to the study, and a Revision: v3.3.2 note was added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Combination Immunotherapy in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combination Immunotherapy in Prostate Cancer Clinical Trial page.